EGFR and fibrosis: Administration of EGFR inhibitors significantly inhibited EGFR phosphorylation, decreased the expression of TGF-β, collagen I and CTGF in the myocardium of animals subjected to HFD, which led to less cardiac fibrosis and dysfunction.